The Nifty 50 closed the week at 23,366.7, still below its 200-day average and 11.2% off its 52-week high, so the regime remains weak but recovering — now into its fourth consecutive day of that read. Breadth is narrow but improving: only 35% of stocks sit above their 200-day average, though 56% have cleared their 50-day, and the advancing cohort has widened by roughly 9 over the last 20 days and nearly 10 over the last 60. The near-term read is neutral-to-up, and the week's transition count — 81 stocks moving from basing to advancing against just 8 moving the other way — is the clearest sign that something constructive is building beneath the index.
Sector picture: what one month and three months say
Over the past month, Communication Services, Health Care and Industrials have been the three strongest sectors, returning 2.9%, 2.1% and 2.0% respectively. Zoom out to three months and the order shifts slightly but the same names dominate: Industrials leads at 10.6%, Health Care follows at 8.9% and Communication Services rounds out the top three at 7.3%. That consistency across both timeframes is notable — these are not one-week rotations but sustained relative strength. At the other end, Financials and Energy have been the clear laggards over three months, down 9.9% and 8.5% respectively, and neither has yet shown the kind of base-building that would change that read.
What is worth watching, however, is that Energy and Consumer Staples are among the sectors where the Stage-2 advancing cohort is expanding fastest over the last 20 days, alongside Materials. That does not erase the three-month damage in Energy, but it does mean more stocks within those sectors are now screening in the advancing stage than they were a month ago — a shift worth tracking as the broader recovery continues.
This week's screening results: transitions and sustained setups
The 81-to-8 transition ratio is the headline from this week's screen. Among the names that cleared the Stage 1-to-2 filter with the highest setup scores, Inspirisys Solutions, Carysil and Rain Industries all came through at 8.7 or above, with Zydus Lifesciences, KDDL and Indo Count Industries close behind at 8.3. Health Care and Consumer Discretionary names feature prominently in that list, consistent with both sectors' medium-term strength. Thyrocare Technologies and Savita Oil Technologies also cleared the transition screen this week.
On the sustained-setups side — stocks that have held a clean advancing structure for longer — Stylam Industries carries the week's highest setup score at 9.8, followed by Venus Remedies and Bliss GVS Pharma at 9.6. Rain Industries appears in both the fresh-transition and sustained lists, which the screen treats as a sign of a well-formed base resolving cleanly. The full transition and sustained-setup tables are rendered below. New 52-week highs on the week numbered 141 against 86 new lows, a net of plus 55 — modest, but positive, and in keeping with a tape that is recovering rather than running.
Volume standouts and what the screen flagged
Several stocks printed outsized volume alongside large single-session moves this week. Ramco Systems moved 18% on volume running at 47 times its normal rate; Bhageria Industries rose 15.8% on 40 times normal volume; Primo Chemicals gained 18.8% on more than 10 times average turnover; and Lotus Eye Hospital and Institute moved 14% on roughly 6.6 times its norm. All four cleared the screener's volume-surge filter. Bhageria Industries and Primo Chemicals sit in Materials, the sector whose Stage-2 cohort is also among the fastest-expanding over the last 20 days. Among the fresh breakouts this week, KDDL and Thyrocare Technologies carried the two highest setup scores at 8.3 and 8.2, with Asian Energy Services the notable Energy-sector name clearing the breakout screen at 7.7 — relevant given Energy's improving internal momentum even as its three-month return remains negative.
| Stock | Sector | Move | Setup |
|---|---|---|---|
| Inspirisys Solutions Ltd | Information Technology | 1→2 | 8.8 |
| Carysil Ltd | Consumer Discretionary | 1→2 | 8.7 |
| Rain Industries Ltd | Materials | 1→2 | 8.7 |
| KDDL Ltd | Consumer Discretionary | 1→2 | 8.3 |
| Zydus Lifesciences Ltd | Health Care | 1→2 | 8.3 |
| Indo Count Industries Ltd | Consumer Discretionary | 1→2 | 8.3 |
| Thyrocare Technologies Ltd | Health Care | 1→2 | 8.2 |
| Savita Oil Technologies Ltd | Materials | 1→2 | 8.2 |
| Stock | Sector | Setup | RS |
|---|---|---|---|
| Stylam Industries Ltd | Industrials | 9.8 | 95 |
| Venus Remedies Ltd | Health Care | 9.6 | 99 |
| Bliss GVS Pharma Ltd | Health Care | 9.6 | 99 |
| Rain Industries Ltd | Materials | 9.2 | 88 |
| Garware Hi-Tech Films Ltd | Materials | 9.2 | 83 |
| Yasho Industries Ltd | Materials | 9.2 | 82 |
| Sandhar Technologies Ltd | Consumer Discretionary | 9.2 | 87 |
| Gland Pharma Ltd | Health Care | 9.2 | 91 |
| Sector | 1D | 1M | 3M | RS | Stage 2 |
|---|---|---|---|---|---|
| Utilities | +1.0% | +0.2% | +6.9% | 64 | 26% |
| Real Estate | +0.5% | -4.9% | -1.1% | 41 | 8% |
| Health Care | +0.4% | +2.1% | +8.9% | 71 | 30% |
| Industrials | +0.3% | +2.0% | +10.6% | 67 | 25% |
| Consumer Staples | +0.3% | -5.8% | -2.7% | 53 | 32% |
| Financials | +0.2% | -7.2% | -9.9% | 58 | 20% |
| Consumer Discretionary | -0.1% | -2.4% | -1.6% | 65 | 19% |
| Communication Services | -0.6% | +2.9% | +7.3% | 63 | 11% |
| Energy | -0.8% | -7.8% | -8.5% | 61 | 43% |
| Materials | -1.1% | -0.9% | +4.8% | 71 | 25% |
| Information Technology | -1.3% | -1.2% | -1.8% | 39 | 18% |
Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.
Nifty +0.4%: Industrials lead, breadth improving on a narrow tape
30% of stocks in Stage 2 and widening; 104 fresh Stage 1-to-2 transitions in five days
Nifty holds 23,989 as Real Estate and IT lead a narrow recovery
Breadth improving, Stage-2 cohort widening, and eight fresh breakouts on the screen today
Nifty +1%, Real Estate leads; Stage-2 cohort at 10-week widest
Breadth improving, 96 fresh Stage 1→2 transitions, Energy & Health Care expanding fastest